Meddenovo
Meddenovo transforms drug design through leveraging AI, molecular modelling, and the unique properties of cyclic peptides to create innovative therapeutic solutions.
Lyon, Francemeddenovo.com ↗
Total raised
€1.4M
€1,383,463
Funding rounds
2
Investors
2
distinct backers
Active since
2024-07
latest 2025-05
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood28
base rate 30% for Other
- ▲ In typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood9
base rate 12% (2+ rounds)
- ▼ Young (<3y)
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-27 | Other | €383k | INVEST 101 | View deal → |
| 2024-07-31 | Pre-Seed | €1.0M | ACT Venture partners | View deal → |
Investors
2Related news
Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software